Home

About BIRAs

Meetings

Membership

Links

Jobs

Journals

 

About BIRAs Aims and Activities Articles of Association Recent Changes BIRAs Committee Sponsorship This Web Site

This Web Site

This web site, along with regular emails, is the main means of regular communication within BIRAs. Every effort is made to keep these pages as current and as up-to-date as possible.

Contributions (see below for examples) to this site are welcome.

This Web Site will eventually contain the following:

• A Diary section, giving details of forthcoming BIRAs meetings, with pre-registration forms, and details of the meetings of other societies and organisations that are pertinent to inflammation science. Where possible, links to appropriate sites or contact details will be given. Organizers of meetings of interest to inflammation researchers are invited to forward details to a member of the committee
 
• Information about BIRAs, such as minutes of committee meetings, business matters, financial details, etc. (Note: these will be restricted to members only).
 
• Details of previous BIRAs meeting and  Meeting Reports for BIRAs meetings (and for some other meetings where available).
 
•  "Viewpoint" articles: Viewpoints are intended to be a forum for brief articles proposing  novel approaches to drug discovery, summarising recent advances or critically reviewing areas of inflammation research, and similar items. Controversial and iconoclastic articles are especially welcome, as is correspondence or articles responding to the views put forward in the Newsletter or during meetings of the Association. Where an area of inflammation science is evidently controversial or in need of clarification, this can help to identify the value of a one-day BIRAs meeting on the topic. 

All members of the Association are invited to submit articles for Viewpoint. In order to   give a forum for novel thoughts and ideas, there is no refereeing of such contributions. The format of Viewpoint articles is largely left to the author(s) to decide: references can be included if appropriate, as can figures and graphs. The overall length should aim to be up to around 4 pages of A4 (single-spaced).
 
• "Sites of inflammation" articles: This occasional series aims to summarise the research activities underway in the research institutes in the UK. For obvious reasons, such articles are perhaps unlikely to be contributed by members working in the pharmaceutical industry.  However, they can be useful ways of stimulating new collaborations or dialogues between groups with common interests. 

All members of the Association are invited to submit articles for this section: the format is as flexible as that described above for Viewpoint. 
 
• Book Reviews: Occasional reviews of books within the very broad area of inflammation  research will be published in the Newsletter. A copy of the review may also be published in Inflammation Research. BIRAs already has agreements with a number of publishers, and hopes to extend this system further. It would be helpful if members of the Association who are willing to contribute reviews to the Newsletter in particular areas of inflammation science would send details to the Web Site Editor. Volumes for review would only be sent after a confirmatory telephone call checking your willingness and availability to complete a review within a reasonable time span. In general, if your review is  published in the Newsletter, you are free to keep the book. Copies of the review are also  forwarded to the publishers for their records. 

• Job Vacancies.
 
• Links to other inflammation societies or organisations, especially the Inflammation Research Association (IRA) in the USA, the European Inflammation Society (EIS) and the IAIS. Other links to potentially useful site will also be included where appropriate. 

Members are encouraged to submit ideas for other features for this web site. It is intended to make this site as useful as possible to members.  Any suggestion, offers or comments on the web site should be addressed to the Editor. All all articles, documents, etc. for submission should be sent as attachments by email or by post. If sending by post, the author should include both a  hard (paper) copy  and a copy on 3.5" disk/RCD, (as either Microsoft Word (*.doc) or rich textformat (*.rtf) documents.